NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
1.170
-0.030 (-2.50%)
Dec 5, 2025, 4:00 PM EST - Market closed
NeuroSense Therapeutics Analyst Ratings
Total Analysts
2
Consensus Rating
Buy
Price Target
$14.00
Upside
+1,096.58%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +1,096.58% | Nov 24, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +1,096.58% | Aug 15, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +1,096.58% | Jul 10, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Initiates $14 | Strong Buy | Initiates | $14 | +1,096.58% | May 12, 2025 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 16, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $7.5 | Strong Buy | Initiates | $7.5 | +541.03% | Jul 17, 2023 |
| Maxim Group | Maxim Group | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +498.29% | Jan 7, 2022 |